Health Care & Life Sciences » Medical Equipment & Supplies | Shanghai Haohai Biological Technology Co. Ltd.

Shanghai Haohai Biological Technology Co. Ltd. | Income Statement

Fiscal year is January-December. All values HKD Millions.
2013
2014
2015
2016
2017
2018
Sales/Revenue
506
649
819
995
1,551
1,831
Cost of Goods Sold (COGS) incl. D&A
76
92
130
165
328
396
Gross Income
430
558
689
829
1,223
1,435
SG&A Expense
247
325
415
505
802
989
EBIT
183
233
275
324
420
446
Unusual Expense
-
-
1
-
-
-
Non Operating Income/Expense
22
1
37
4
2
95
Interest Expense
-
-
-
-
3
3
Pretax Income
210
271
395
426
535
608
Income Tax
31
40
58
65
71
83
Equity in Affiliates
-
-
-
1
3
14
Consolidated Net Income
179
231
337
363
461
539
Net Income
179
231
337
356
429
491
Net Income After Extraordinaries
179
231
337
356
429
491
Net Income Available to Common
179
231
337
356
429
491
EPS (Basic)
1.11
1.45
2.29
2.23
2.69
3.07
Basic Shares Outstanding
160
160
147
160
160
160
EPS (Diluted)
1.12
1.44
2.29
2.23
2.68
3.07
Diluted Shares Outstanding
160
160
147
160
160
160
EBITDA
199
261
316
365
494
543
Non-Operating Interest Income
5
5
47
68
69
70
Minority Interest Expense
-
-
-
7
32
48

About Shanghai Haohai Biological Technology Co.

View Profile
Address
23/F, WenGuang Plaza
Shanghai Shanghai 200052
China
Employees -
Website http://www.3healthcare.com
Updated 07/08/2019
Shanghai Haohai Biological Technology Co., Ltd. engages in the manufacture and sale of biologicals, medical hyaluronate, intraocular lens, research and development of biological engineering and pharmaceutical products and the provision of related services. It operates through the following geographical segments: Mainland China, the United States of America, the United Kingdom, and Other Countries. The company was founded on January 24, 2007 and is headquartered in Shanghai, China.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.